Article
Whether AI+CDK4/6i+HP is suitable treatment for three positive metastatic breast cancer patient with renal insufficiency caused by type 2 diabetes
2023-12-07
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Hormone-receptor positive (HR+)，ERBB2 gene mutation(HER2+)breast cancer is a very common type of breast cancer, but it is relatively rare for metastatic breast cancer (MBC) who are newly treated and have renal insufficiency. In previous studies, no long-term survival reports have been found for such patients. In order to clarify the above issues, we have innovat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc08907a-39dc-54df-b275-766e8ed50638
- DOI
- 10.21203/rs.3.rs-3709512/v1